Browsing: promising
Researchers at the University of Texas MD Anderson Cancer Center will present promising results from clinical trials in three summaries…
Hepatocellular carcinoma (HCC) represents the most common malignancy in Egypt and worldwide. However, non -invasive diagnostic/prognostic biomarkers for early HCC…
Preoperative treatment with the new drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of…
More than a million people die each year from infections with antimicrobial-resistant pathogens, and the problem is growing. Meanwhile, the…
In a recent prospective observational cohort study published in eClinical Medicineinvestigators evaluated a modified total neoadjuvant therapy (TNT) regimen in…
In a recent review published in the journal Cell, Researchers summarize and clarify recent research and clinical trials that highlight…
BioCryst Pharmaceuticals, Inc. announced today new real-world data showing that patients with hereditary angioedema (HAE) who have normal levels and…
Patients with chronic obstructive pulmonary disease with type 2 inflammation may soon have access to a new drug – dupilumab…
In a 10-center study, microwave ablation offered progression-free survival rates and fewer complications than surgery in treating a form of…
The global population of patients with diabetic wounds is expected to increase between 9.1 and 26.1 million by 2030. Diabetic…